Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 173 results:
Συντάκτης Τίτλος [ Τύπος(Asc)] Έτος
Φίλτρα: Συντάκτης is Roilides, Emmanuel  [Clear All Filters]
Journal Article
Kefala-Agoropoulou, K., Protonotariou E., Vitti D., Sarafidou S., Anastasiou A., Kollios K., et al. (2010).  Life-threatening infection due to community-acquired methicillin-resistant Staphylococcus aureus: case report and review.. Eur J Pediatr. 169(1), 47-53.
Roilides, E., & Antachopoulos C. (2016).  Isavuconazole: an azole active against mucormycosis.. Lancet Infect Dis. 16(7), 761-762.
Antoniadi, K., Iosifidis E., Vasileiou E., Tsipou C., Lialias I., Papakonstantinou E., et al. (2020).  Invasive Mucormycosis in Children With Malignancies: Report From the Infection Working Group of the Hellenic Society of Pediatric Hematology-Oncology.. J Pediatr Hematol Oncol.
Antoniadi, K., Iosifidis E., Vasileiou E., Tsipou C., Lialias I., Papakonstantinou E., et al. (2020).  Invasive Mucormycosis in Children With Malignancies. Journal of Pediatric Hematology/Oncology. Publish Ahead of Print,
Pana, Z. Dorothea, Seidel D., Skiada A., Groll A. H., Petrikkos G., Cornely O. A., et al. (2016).  Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries.. BMC Infect Dis. 16(1), 667.
Dornbusch, H. Jürgen, Manzoni P., Roilides E., Walsh T. J., & Groll A. H. (2009).  Invasive fungal infections in children.. Pediatr Infect Dis J. 28(8), 734-7.
Pana, Z. Dorothea, Kotzadamis D., & Roilides E. (2018).  Invasive Candidiasis in Pediatric Intensive Care Unit: More Challenges.. Pediatr Infect Dis J. 37(12), 1309-1311.
Roilides, E. (2011).  Invasive candidiasis in neonates and children.. Early Hum Dev. 87 Suppl 1, S75-6.
Walsh, T. J., Katragkou A., Chen T., Salvatore C. M., & Roilides E. (2019).  Invasive Candidiasis in Infants and Children: Recent Advances in Epidemiology, Diagnosis, and Treatment.. J Fungi (Basel). 5(1), 
Papachristou, S., Iosifidis E., & Roilides E. (2019).  Invasive Aspergillosis in Pediatric Leukemia Patients: Prevention and Treatment.. J Fungi (Basel). 5(1), 
Tragiannidis, A., Roilides E., Walsh T. J., & Groll A. H. (2012).  Invasive aspergillosis in children with acquired immunodeficiencies.. Clin Infect Dis. 54(2), 258-67.
Pyrpasopoulou, A., Pitsava G., Iosifidis E., Imvrios G., Massa E., Mouloudi E., et al. (2018).  Intravenous fosfomycin in patients with liver disease for extensively drug-resistant Gram-negative bacteria.. J Infect. 77(5), 448-454.
Katragkou, A., Kruhlak M. J., Simitsopoulou M., Chatzimoschou A., Taparkou A., Cotten C. J., et al. (2010).  Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents.. J Infect Dis. 201(12), 1941-9.
Maltezou, H. C., Kontopidou F., Katerelos P., Daikos G., Roilides E., & Theodoridou M. (2013).  Infections caused by carbapenem-resistant Gram-negative pathogens in hospitalized children.. Pediatr Infect Dis J. 32(4), e151-4.
Petraitis, V., Petraitiene R., Antachopoulos C., Hughes J. E., Cotton M. P., Kasai M., et al. (2013).  Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism.. Med Mycol. 51(1), 72-82.
Katragkou, A., McCarthy M., Alexander E. L., Antachopoulos C., Meletiadis J., Jabra-Rizk M. Ann, et al. (2015).  In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.. J Antimicrob Chemother. 70(2), 470-8.
Katragkou, A., McCarthy M., Meletiadis J., Hussain K., Moradi P. W., Strauss G. E., et al. (2017).  In vitro combination therapy with isavuconazole against Candida spp.. Med Mycol. 55(8), 859-868.
Katragkou, A., McCarthy M., Meletiadis J., Petraitis V., Moradi P. W., Strauss G. E., et al. (2014).  In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds.. Antimicrob Agents Chemother. 58(11), 6934-7.
Antachopoulos, C., Katragkou A., & Roilides E. (2012).  Immunotherapy against invasive mold infections.. Immunotherapy. 4(1), 107-20.
Simitsopoulou, M., Roilides E., & Walsh T. J. (2011).  Immunomodulatory properties of antifungal agents on phagocytic cells.. Immunol Invest. 40(7-8), 809-24.
Geladari, A., Simitsopoulou M., Antachopoulos C., & Roilides E. (2020).  Immunomodulatory Effects of Colistin on Host Responses against Carbapenem-resistant Klebsiella pneumoniae Biofilms.. Int J Antimicrob Agents. 106182.
Roilides, E., Lyman C. A., Panagopoulou P., & Chanock S. (2003).  Immunomodulation of invasive fungal infections.. Infect Dis Clin North Am. 17(1), 193-219.
Roilides, E., & Simitsopoulou M. (2017).  Immune responses to Mucorales growth forms: Do we know everything?. Virulence. 8(8), 1489-1491.
Gholinejad-Ghadi, N., Shokohi T., Seifi Z., Aghili S. Reza, Roilides E., Nikkhah M., et al. (2018).  Identification of Mucorales in patients with proven invasive mucormycosis by polymerase chain reaction in tissue samples.. Mycoses. 61(12), 909-915.
Lewis, R. E., Lortholary O., Spellberg B., Roilides E., Kontoyiannis D. P., & Walsh T. J. (2012).  How does antifungal pharmacology differ for mucormycosis versus aspergillosis?. Clin Infect Dis. 54 Suppl 1, S67-72.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές